New Zealand markets open in 2 hours 35 minutes

Thermo Fisher Scientific Inc. (TMO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
576.95+0.78 (+0.14%)
As of 01:25PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 230.36B
Enterprise value 256.32B
Trailing P/E 33.32
Forward P/E 25.58
PEG ratio (5-yr expected) 4.48
Price/sales (ttm)5.15
Price/book (mrq)5.23
Enterprise value/revenue 5.71
Enterprise value/EBITDA 21.46

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-1.93%
S&P500 52-week change 3-9.08%
52-week high 3618.36
52-week low 3475.77
50-day moving average 3562.62
200-day moving average 3547.55

Share statistics

Avg vol (3-month) 31.57M
Avg vol (10-day) 31.6M
Shares outstanding 5392.2M
Implied shares outstanding 6N/A
Float 8390.17M
% held by insiders 10.24%
% held by institutions 190.58%
Shares short (12 Jan 2023) 43.05M
Short ratio (12 Jan 2023) 41.93
Short % of float (12 Jan 2023) 40.78%
Short % of shares outstanding (12 Jan 2023) 40.78%
Shares short (prior month 14 Dec 2022) 43.04M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 40.20%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 40.23
Payout ratio 46.81%
Dividend date 315 Jan 2023
Ex-dividend date 413 Dec 2022
Last split factor 23:2
Last split date 305 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 15.47%
Operating margin (ttm)18.94%

Management effectiveness

Return on assets (ttm)5.53%
Return on equity (ttm)16.35%

Income statement

Revenue (ttm)44.91B
Revenue per share (ttm)114.58
Quarterly revenue growth (yoy)7.00%
Gross profit (ttm)19.5B
EBITDA 11.89B
Net income avi to common (ttm)6.95B
Diluted EPS (ttm)17.63
Quarterly earnings growth (yoy)-4.90%

Balance sheet

Total cash (mrq)8.52B
Total cash per share (mrq)21.8
Total debt (mrq)34.49B
Total debt/equity (mrq)78.12
Current ratio (mrq)1.48
Book value per share (mrq)112.61

Cash flow statement

Operating cash flow (ttm)9.15B
Levered free cash flow (ttm)5.7B